Antibody-Drug Conjugates for Cancer Therapy: Chemistry to Clinical Implications
Antibody-Drug Conjugates for Cancer Therapy: Chemistry to Clinical Implications
About this item
Full title
Author / Creator
Publisher
Switzerland: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: MDPI AG
Subjects
More information
Scope and Contents
Contents
Chemotherapy is one of the major therapeutic options for cancer treatment. Chemotherapy is often associated with a low therapeutic window due to its poor specificity towards tumor cells/tissues. Antibody-drug conjugate (ADC) technology may provide a potentially new therapeutic solution for cancer treatment. ADC technology uses an antibody-mediated...
Alternative Titles
Full title
Antibody-Drug Conjugates for Cancer Therapy: Chemistry to Clinical Implications
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_980ab49beba54087999f5a5745ed86cd
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_980ab49beba54087999f5a5745ed86cd
Other Identifiers
ISSN
1424-8247
E-ISSN
1424-8247
DOI
10.3390/ph11020032
